Notice of Pre-Submission Technical Assistance Webinars and Frequently Asked Questions for NHLBI RFA-HL-20-025 "Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (UG3/UH3 - Clinical Trial Optional)

Notice Number: NOT-HL-19-720

Key Dates
Release Date: October 8, 2019

Related Announcements

RFA-HL-20-025: Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (UG3/UH3 - Clinical Trial Optional)

RFA-HL-20-026: Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) Research Coordinating Center (U24 - Clinical Trial Not Allowed)

NOT-HL-17-520: Notice of Intent to Publish a Funding Opportunity Announcement for Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (U01)

NOT-HL-17-521: Notice of Intent to Publish a Funding Opportunity Announcement for Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV Data Coordinating Center (HLB SIMPLe DCC) (U24)

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On October 2, 2019, the National Heart, Lung, and Blood Institute (NHLBI) and the Fogarty International Center (FIC) issued a Funding Opportunity Announcement (FOA): RFA-HL-20-025, entitled " Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe)” (UG3/UH3 - Clinical Trial Optional).

Pre-submission technical assistance webinars are being offered to inform potential applicants about RFA-HL-20-025 (HLB SIMPLe (UG3/UH3)) and will include a review of the purpose and objectives of this FOA, application and peer review requirements, and budget considerations.

All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar in order to maximize the use of time. Specific questions should be sent via email to ctrisgrants@nih.gov no later than 48 hours prior to the webinar.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-HL-20-025 .

Session Dates and times are as follows:

  • Tuesday, October 15, 2019 at 8:30 a.m. EDT

Join WebEx

Event number: 620 036 247
Event password: simple
Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e0006d4c00682fd1c709a4bb73afead27

Join the Audio Conference

Call-in toll number (US/Canada): 1-650-479-3208

Global call-in numbers: https://nih.webex.com/nih/globalcallin.php?serviceType=EC&ED=809509702&tollFree=0

Access code: 620 036 247

  • Thursday, October 24, 2019 at 10:00 a.m. EDT

Join WebEx

Event number: 625 580 978
Event password: simple
Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e067c764b03462fe206fa49f548dd3da4

Join the Audio Conference

Call-in toll number (US/Canada): 1-650-479-3208

Global call-in numbers: https://nih.webex.com/nih/globalcallin.php?serviceType=EC&ED=809509702&tollFree=0

Access code: 625 580 978

This Notice also provides information regarding the availability of Frequently Asked Questions (FAQs) to address common questions from potential applicants regarding RFA-HL-20-025, which are available at: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/rfa-hl-20-025.

All applicants are encouraged to review the FAQs prior to submitting an application. The FAQs may be updated, as needed. Applicants are encouraged to check for updates to the FAQs regularly until the submission date.

Inquiries

Please direct all inquiries to:

Brad Newsome, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8170
Email: brad.newsome@nih.gov

Geetha P. Bansal, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-496-1492
Email: geetha.bansal@nih.gov